Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antibody Drug Conjugates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116178386A reveals a novel LE14 synthesis route. Achieve higher purity and cost reduction in ADC manufacturing with stable intermediates.
Patent CN113166057B reveals efficient synthesis of (S)-6-hydroxytryptophan. Discover cost reduction in ADC manufacturing and reliable supply chain solutions.
Patent CN104945468A reveals a metal-free route for MMAF impurities. This method ensures high purity and supply chain stability for ADC manufacturing.
Novel patent CN113825759A details a safe, scalable route to maytansinol using Grignard reagents, eliminating hazardous hydride reductions for reliable API intermediate supply.
Novel Friedel-Crafts route avoids nitration for ADC intermediates. High yield, scalable process for camptothecin derivatives and pharmaceutical manufacturing.
Patent CN110225904A details a modular synthesis for cytotoxic benzodiazepine derivatives, offering improved purity and scalable manufacturing for antibody-drug conjugate intermediates.
Patent CN115651043A reveals a streamlined one-step synthesis for PNU-159682 derivatives, offering cost reduction and scalable supply chain solutions for ADC manufacturing.
Advanced purification patent CN121021353A enables high-purity ADC linker production with simplified crystallization processes for reliable pharmaceutical intermediate supply chains.
Patent CN115109118A introduces a solid-phase synthesis method for DS-8201 intermediates, offering superior purity and cost reduction for ADC manufacturing.
Patent CN116217655A reveals a stable synthesis route for ADC linker intermediate Formula I. Achieve high purity and reduced cytotoxic exposure for reliable supply chains.
Patent CN116102615A details a modular synthesis for cytotoxic benzodiazepines. This report analyzes cost reduction in ADC payload manufacturing and supply chain reliability for high-purity pharmaceutical intermediates.
Novel synthetic route for LND1088 linker avoids low-yield intermediates, ensuring scalable production and cost efficiency for ADC developers.
Patent CN116217654A reveals a stable intermediate route for LE14 ADC payloads, offering cost reduction in ADC manufacturing and reliable supply chain solutions.
Patent CN115448926A details a scalable method for indolinobenzodiazepine derivatives using iron reduction and palladium catalysis, offering significant cost reduction in API manufacturing.
Patent CN109963835B reveals a streamlined 2-step convergent synthesis for MMAF analogs, offering significant cost reduction in ADC manufacturing and enhanced supply chain reliability.
Patent CN107531680B reveals a novel route for toxin intermediates, offering high optical purity and yield for cost reduction in ADC toxin manufacturing.
Patent CN116496189B reveals copper-catalyzed synthesis of N-acyl sulfenamides. Enables efficient asymmetric disulfide production for ADCs and pharmaceutical intermediates with mild conditions.